Viatris Will Tread A Different Path

Mylan-Upjohn Combination Neither Pure Generics Nor Big Pharma Player

Choices
The Viatris entity formed by merging Mylan and Upjohn will aim to chart a path between generics and big pharma • Source: Shutterstock

More from Deals

More from Business